Frank Ruffo, Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS), sold 25,646 shares at $15.55 ($399K) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Open-market sale of $399k ACRS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.55 | 12,823 | $199K | 50.0% |
| 2 | $15.55 | 12,823 | $199K | 50.0% |
| Total | $15.55 avg | 25,646 | $399K | 100% |
| Filing → |
| ACRS | SELL | 2021-04-26 | $3.0M | — | Filing → |
| ACRS | BUY | 2018-05-07 | $23K | — | Filing → |
| ACRS | BUY | 2018-04-09 | $21K | — | Filing → |